Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific CR2 CD21 ENSG00000117322 Complement component (3d/Epstein Barr virus) receptor 2 1 207454230-207489895 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002659, HPA052942, HPA060715 Supported Group enriched 22 appendix: 70.8;lymph node: 207.6;spleen: 101.3;tonsil: 159.4 kidney: 6.1 FAM129C BCNP1, FLJ39802 ENSG00000167483 Family with sequence similarity 129, member C 19 17523301-17553839 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043277 Approved Group enriched 15 appendix: 14.5;bone marrow: 11.3;lymph node: 28.5;spleen: 37.6;tonsil: 9.7 gallbladder: 1.3 MS4A1 B1, Bp35, CD20, MS4A2 ENSG00000156738 Membrane-spanning 4-domains, subfamily A, member 1 11 60455752-60470760 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000015, HPA014341, HPA014391 Supported Group enriched 15 appendix: 249.3;lymph node: 780.6;spleen: 476.2;tonsil: 821.5 urinary bladder: 39.8 EN1 ENSG00000163064 Engrailed homeobox 1 2 118842171-118847678 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level No evidence CAB014884, HPA073141 Approved Supported Nucleus
Nucleoli Group enriched 13 adipose tissue: 1.3;breast: 1.0;lymph node: 1.9;skeletal muscle: 4.7;skin: 2.2 testis: 0.1 FCRL3 CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e ENSG00000160856 Fc receptor-like 3 1 157674321-157700857 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015508 Approved Group enriched 12 appendix: 18.8;lymph node: 56.6;spleen: 37.3;tonsil: 33.6 urinary bladder: 2.9 AICDA AID, ARP2, CDA2, HIGM2 ENSG00000111732 Activation-induced cytidine deaminase 12 8602166-8612871 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 11 appendix: 5.1;lymph node: 18.9;tonsil: 11.5 spleen: 1.0 CD19 ENSG00000177455 CD19 molecule 16 28931939-28939346 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016110 Supported Group enriched 11 appendix: 38.8;lymph node: 85.0;spleen: 48.2;tonsil: 70.8 urinary bladder: 5.7 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Approved Group enriched 10 appendix: 22.9;lymph node: 61.9;spleen: 41.3;tonsil: 54.0 urinary bladder: 4.5 CLEC17A FLJ45910 ENSG00000187912 C-type lectin domain family 17, member A 19 14583084-14611157 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 appendix: 17.3;lymph node: 30.8;spleen: 19.8;tonsil: 29.7 urinary bladder: 2.4 FCRLA FCRL, FCRLa, FCRLb, FCRLc1, FCRLc2, FCRLd, FCRLe, FCRLM1, FCRLX, FREB, MGC4595 ENSG00000132185 Fc receptor-like A 1 161706972-161714352 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016545 Supported Group enriched 10 appendix: 32.5;lymph node: 81.6;spleen: 57.4;tonsil: 90.1 urinary bladder: 6.5 P2RX5 LRH-1, P2X5 ENSG00000083454 Purinergic receptor P2X, ligand gated ion channel, 5 17 3672199-3696404 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA021948, HPA067827 Supported Supported Cytosol Group enriched 10 appendix: 42.6;lymph node: 90.9;spleen: 75.5;tonsil: 48.4 bone marrow: 6.2 SERPINA9 CENTERIN, GCET1, SERPINA11b ENSG00000170054 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9 14 94462717-94479689 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 10 appendix: 17.7;lymph node: 51.0;tonsil: 68.9 epididymis: 4.5 TNFRSF13C BAFFR, CD268 ENSG00000159958 Tumor necrosis factor receptor superfamily, member 13C 22 41922023-41926818 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003246, CAB008380 Supported Uncertain Nucleus Group enriched 10 appendix: 23.8;lymph node: 46.7;spleen: 44.4;tonsil: 51.9 bone marrow: 4.0 CHIT1 CHI3, CHIT ENSG00000133063 Chitinase 1 (chitotriosidase) 1 203212827-203273641 Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010575 Approved Group enriched 9 bone marrow: 31.3;breast: 10.7;cervix, uterine: 13.4;lung: 53.2;lymph node: 21.5 prostate: 2.9 MEF2B RSRFR2 ENSG00000213999 Myocyte enhancer factor 2B 19 19145568-19170289 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004734 Supported Group enriched 9 appendix: 18.2;lymph node: 46.3;tonsil: 28.2 spleen: 3.3 CD72 CD72b, LYB2 ENSG00000137101 CD72 molecule 9 35609533-35646810 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB002505, HPA044658 Supported Approved Nucleus
Mitochondria Group enriched 8 appendix: 26.2;lymph node: 72.0;spleen: 65.9;tonsil: 44.3 urinary bladder: 6.2 FCRL2 CD307b, FCRH2, IRTA4, SPAP1 ENSG00000132704 Fc receptor-like 2 1 157745733-157777132 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 appendix: 16.9;lymph node: 28.7;spleen: 26.3;tonsil: 24.6 rectum: 3.1 LTB p33, TNFC, TNFSF3 ENSG00000227507 Lymphotoxin beta (TNF superfamily, member 3) 6 31580525-31582522 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048884 Approved Approved Centrosome Group enriched 8 appendix: 19.4;lymph node: 22.5;spleen: 26.4;tonsil: 10.6 bone marrow: 2.6 BTLA BTLA1, CD272 ENSG00000186265 B and T lymphocyte associated 3 112463968-112499561 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047211, HPA062029 Supported Group enriched 7 appendix: 14.7;lymph node: 29.6;spleen: 14.8;tonsil: 25.7 urinary bladder: 3.1 CLEC4M CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN ENSG00000104938 C-type lectin domain family 4, member M 19 7763149-7769605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033689, CAB033691, HPA042661 Supported Group enriched 7 liver: 34.7;lymph node: 20.6;placenta: 12.4 testis: 3.3 CNR2 CB2 ENSG00000188822 Cannabinoid receptor 2 (macrophage) 1 23870526-23913362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009719 Uncertain Group enriched 7 appendix: 3.2;lymph node: 8.8;spleen: 8.1;tonsil: 7.2 bone marrow: 1.0 CXCL13 ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13 ENSG00000156234 Chemokine (C-X-C motif) ligand 13 4 77511753-77611834 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052613 Uncertain Group enriched 7 appendix: 170.3;lymph node: 606.7;spleen: 430.3;tonsil: 411.9 urinary bladder: 60.1 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Approved Group enriched 7 appendix: 22.9;lymph node: 48.1;spleen: 53.7;tonsil: 39.4 adipose tissue: 5.7 KRT73 K6IRS3, KRT6IRS3 ENSG00000186049 Keratin 73, type II 12 52607570-52618559 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044031 Supported Group enriched 7 lymph node: 2.6;skin: 12.2 appendix: 1.0 TLR10 CD290 ENSG00000174123 Toll-like receptor 10 4 38772239-38782990 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 appendix: 22.0;lymph node: 52.3;spleen: 35.2;tonsil: 46.8 urinary bladder: 5.7 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CD79A IGA, MB-1 ENSG00000105369 CD79a molecule, immunoglobulin-associated alpha 19 41877120-41881372 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000019 Supported Group enriched 6 appendix: 275.4;lymph node: 522.9;spleen: 324.4;tonsil: 440.3 stomach: 62.7 CETP BPIFF ENSG00000087237 Cholesteryl ester transfer protein, plasma 16 56961850-56983845 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 adipose tissue: 36.8;liver: 21.6;lymph node: 47.1;placenta: 50.0;spleen: 79.2 thyroid gland: 8.4 CLEC4G LSECtin, UNQ431 ENSG00000182566 C-type lectin domain family 4, member G 19 7728957-7733906 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003789, HPA014044 Supported Group enriched 6 adipose tissue: 18.5;liver: 27.6;lymph node: 17.0 urinary bladder: 3.5 DNMT3L MGC1090 ENSG00000142182 DNA (cytosine-5-)-methyltransferase 3-like 21 44246339-44262216 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA055234, HPA066780 Uncertain Approved Nuclear speckles Group enriched 6 kidney: 7.4;liver: 10.8;lymph node: 2.3 spleen: 1.1 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002513, HPA040368, HPA062096, HPA064404 Supported Supported Nucleoplasm Group enriched 6 appendix: 37.8;lymph node: 62.5;spleen: 37.2;tonsil: 45.5 urinary bladder: 8.1 RGS13 ENSG00000127074 Regulator of G-protein signaling 13 1 192636138-192660306 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA044952 Uncertain Group enriched 6 appendix: 14.8;lymph node: 69.2;tonsil: 38.3 small intestine: 7.3 SP140 LYSP100-A, LYSP100-B ENSG00000079263 SP140 nuclear body protein 2 230203110-230313215 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006162, HPA067493 Supported Approved Nucleoli fibrillar center
Mitochondria Group enriched 6 appendix: 34.0;lymph node: 65.2;spleen: 38.9;tonsil: 52.9 urinary bladder: 7.9 STAP1 BRDG1, STAP-1 ENSG00000035720 Signal transducing adaptor family member 1 4 67558728-67607337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038529 Supported Uncertain Nucleoplasm
Vesicles Group enriched 6 appendix: 24.7;kidney: 13.1;lymph node: 60.3;spleen: 27.0;tonsil: 58.9 testis: 6.1 TIMD4 ENSG00000145850 T-cell immunoglobulin and mucin domain containing 4 5 156919282-156963255 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015625, CAB026027 Approved Approved Plasma membrane
Cytosol Group enriched 6 lymph node: 64.4;testis: 161.6 adipose tissue: 17.7 TMEM156 FLJ23235 ENSG00000121895 Transmembrane protein 156 4 38966744-39032922 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 6 appendix: 12.2;lymph node: 28.1;spleen: 15.4;tonsil: 25.3;urinary bladder: 5.9 gallbladder: 3.1 AC018755.18 ENSG00000268500 19 51612091-51646889 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA009085 Approved Group enriched 5 appendix: 7.3;bone marrow: 14.2;lymph node: 3.6;spleen: 5.0 urinary bladder: 1.4 ANKRD55 FLJ11795 ENSG00000164512 Ankyrin repeat domain 55 5 56099678-56233359 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051049 Approved Group enriched 5 lymph node: 4.2;testis: 17.2 tonsil: 1.9 BANK1 BANK, FLJ20706 ENSG00000153064 B-cell scaffold protein with ankyrin repeats 1 4 101411286-102074812 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037002 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 47.6;lymph node: 97.9;spleen: 78.5;thyroid gland: 21.5;tonsil: 90.9 urinary bladder: 13.3 CCL19 CKb11, ELC, exodus-3, MIP-3b, SCYA19 ENSG00000172724 Chemokine (C-C motif) ligand 19 9 34689567-34691277 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067758 Supported Group enriched 5 adipose tissue: 171.7;appendix: 807.5;lymph node: 715.5;tonsil: 578.1 urinary bladder: 110.3 CD79B B29, IGB ENSG00000007312 CD79b molecule, immunoglobulin-associated beta 17 63928740-63932354 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009178, CAB009751 Approved Uncertain Nucleoplasm
Plasma membrane
Cytosol Group enriched 5 appendix: 94.7;lymph node: 315.6;spleen: 160.3;tonsil: 196.1 bone marrow: 36.2 FCRL4 CD307d, FCRH4, IGFP2, IRTA1 ENSG00000163518 Fc receptor-like 4 1 157573749-157598080 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054030 Approved Group enriched 5 appendix: 3.7;lymph node: 4.5;tonsil: 10.1 spleen: 1.2 HLA-DOB ENSG00000241106 Major histocompatibility complex, class II, DO beta 6 32812763-32817048 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013846 Approved Group enriched 5 lymph node: 19.9;spleen: 18.8;tonsil: 31.8;urinary bladder: 8.6 colon: 3.6 HTR3A 5-HT3A, 5-HT3R, HTR3 ENSG00000166736 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11 113974881-113990313 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 5 appendix: 2.9;lymph node: 7.9;tonsil: 7.4 small intestine: 1.1 IL24 C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16 ENSG00000162892 Interleukin 24 1 206897443-206904139 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025972 Uncertain Group enriched 5 appendix: 17.9;lymph node: 37.6;spleen: 30.0;tonsil: 28.5 urinary bladder: 5.6 LIMD2 MGC10986 ENSG00000136490 LIM domain containing 2 17 63695902-63701172 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062867 Approved Vesicles Group enriched 5 appendix: 145.1;bone marrow: 71.3;lymph node: 259.7;spleen: 195.3;tonsil: 145.7 urinary bladder: 31.4 SIT1 SIT ENSG00000137078 Signaling threshold regulating transmembrane adaptor 1 9 35649295-35650950 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018506 Supported Group enriched 5 appendix: 25.6;lymph node: 56.9;spleen: 22.3;tonsil: 30.9 urinary bladder: 6.3 AC019206.1 ENSG00000279229 2 69902350-69902709 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 lymph node: 9.4 cerebral cortex: 7.1 AC123512.1 ENSG00000279037 12 91986626-91993403 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 lymph node: 9.8 urinary bladder: 5.7 AC123512.3 ENSG00000282896 Uncharacterized protein C12orf79 12 91987578-91993403 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 lymph node: 3.8 appendix: 2.1 ACAP1 CENTB1, KIAA0050 ENSG00000072818 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 17 7336529-7351478 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062130 Approved Vesicles Tissue enhanced 0 lymph node: 95.5 spleen: 71.2 ADGRG5 GPR114, PGR27 ENSG00000159618 Adhesion G protein-coupled receptor G5 16 57542421-57591681 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA007133 Supported Approved Nucleoplasm
Nuclear membrane
Vesicles Tissue enhanced 0 lymph node: 11.3;tonsil: 8.9 appendix: 6.2 AIM2 PYHIN4 ENSG00000163568 Absent in melanoma 2 1 159062484-159147096 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031365, HPA040309 Uncertain Supported Nucleoplasm
Mitochondria
Cytosol Tissue enhanced 0 lymph node: 53.2;spleen: 31.4;tonsil: 41.8 appendix: 26.9 ANKRD34B DP58 ENSG00000189127 Ankyrin repeat domain 34B 5 80556755-80570488 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA043327, HPA061740 Uncertain Approved Lipid droplets Tissue enhanced 0 bone marrow: 1.1;lymph node: 1.0;tonsil: 1.2 kidney: 0.7 ANXA2R AXIIR, C5orf39 ENSG00000177721 Annexin A2 receptor 5 43039081-43043170 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA051482 Uncertain Approved Nucleoplasm
Aggresome
Cytosol
Cytoplasmic bodies Tissue enhanced 0 lymph node: 22.2 spleen: 15.7 ARHGAP15 BM046 ENSG00000075884 Rho GTPase activating protein 15 2 143091362-143768352 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032125 Uncertain Uncertain Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 lymph node: 66.2 spleen: 60.5 ARHGAP30 FLJ00267 ENSG00000186517 Rho GTPase activating protein 30 1 161046946-161069970 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036300 Uncertain Supported Vesicles Tissue enhanced 0 lymph node: 87.3;spleen: 82.0 appendix: 75.4 ARL11 ARLTS1, FLJ33930 ENSG00000152213 ADP-ribosylation factor-like 11 13 49628299-49633872 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040855, HPA040887 Uncertain Tissue enhanced 0 lymph node: 7.7 spleen: 6.4 AURKB Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5 ENSG00000178999 Aurora kinase B 17 8204733-8210600 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005862, HPA037708 Supported Supported Nucleoplasm
Midbody Tissue enhanced 0 lymph node: 45.0;tonsil: 35.2 bone marrow: 28.2 BACH2 BTBD25 ENSG00000112182 BTB and CNC homology 1, basic leucine zipper transcription factor 2 6 89926529-90296908 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051384, HPA058384 Supported Supported Nucleus
Cytosol Tissue enhanced 0 lymph node: 21.4 tonsil: 12.5 BATF B-ATF, BATF1, SFA-2 ENSG00000156127 Basic leucine zipper transcription factor, ATF-like 14 75522425-75547015 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059588, HPA064962 Approved Validated Nucleoplasm Tissue enhanced 0 lymph node: 31.9 appendix: 27.3 BCAS4 CNOL, FLJ20495 ENSG00000124243 Breast carcinoma amplified sequence 4 20 50794894-50882676 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038812 Uncertain Approved Intermediate filaments
Cytosol Tissue enhanced 0 lymph node: 25.7 tonsil: 22.0 BCL11B CTIP-2, CTIP2, hRIT1-alpha, ZNF856B ENSG00000127152 B-cell CLL/lymphoma 11B (zinc finger protein) 14 99169287-99271524 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049117 Supported Supported Approved Nucleus
Nucleoli fibrillar center Tissue enhanced 0 lymph node: 12.4;skin: 18.8 tonsil: 7.7 BIRC3 API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49 ENSG00000023445 Baculoviral IAP repeat containing 3 11 102317450-102339403 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002317 Supported Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 139.7 appendix: 121.3 BTK AGMX1, ATK, IMD1, PSCTK1, XLA ENSG00000010671 Bruton agammaglobulinemia tyrosine kinase X 101349447-101390796 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001198, HPA002028, CAB016689 Supported Supported Vesicles Tissue enhanced 0 lymph node: 66.0;tonsil: 73.6 spleen: 53.6 CARD11 BIMP3, CARMA1 ENSG00000198286 Caspase recruitment domain family, member 11 7 2906141-3043945 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052984 Approved Tissue enhanced 0 lymph node: 55.1;spleen: 41.0 appendix: 29.3 CCL17 ABCD-2, SCYA17, TARC ENSG00000102970 Chemokine (C-C motif) ligand 17 16 57404767-57416062 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002583 Approved Tissue enhanced 0 appendix: 11.5;lymph node: 10.1 tonsil: 5.6 CCL21 6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4 ENSG00000137077 Chemokine (C-C motif) ligand 21 9 34709005-34710124 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005067, HPA051210 Supported Tissue enhanced 0 lymph node: 3206.9 tonsil: 984.2 CCR6 BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22 ENSG00000112486 Chemokine (C-C motif) receptor 6 6 167111807-167139696 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB006820, HPA014488 Approved Tissue enhanced 0 lymph node: 20.6;tonsil: 33.8 spleen: 17.3 CD180 LY64, Ly78, RP105 ENSG00000134061 CD180 molecule 5 67179613-67196799 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003740 Supported Tissue enhanced 0 lymph node: 27.8;tonsil: 22.2 spleen: 18.0 CD2 SRBC ENSG00000116824 CD2 molecule 1 116754385-116769228 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002430, HPA003883 Supported Tissue enhanced 0 lymph node: 132.9 tonsil: 73.5 CD22 SIGLEC-2, SIGLEC2 ENSG00000012124 CD22 molecule 19 35319261-35347355 CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002418, HPA024353 Supported Tissue enhanced 0 lymph node: 269.3;ovary: 163.3;spleen: 155.4;tonsil: 219.0 appendix: 102.4 CD247 CD3H, CD3Q, CD3Z ENSG00000198821 CD247 molecule 1 167430640-167518610 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004651, HPA008750 Supported Tissue enhanced 0 lymph node: 66.0;spleen: 49.4 tonsil: 34.9 CD27 S152, TNFRSF7, Tp55 ENSG00000139193 CD27 molecule 12 6444867-6451718 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002420, HPA038936 Supported Tissue enhanced 0 lymph node: 142.5;tonsil: 90.3 spleen: 69.5 CD28 ENSG00000178562 CD28 molecule 2 203706475-203738912 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070003 Supported Tissue enhanced 0 lymph node: 32.9;placenta: 20.8 appendix: 19.2 CD37 TSPAN26 ENSG00000104894 CD37 molecule 19 49335171-49343335 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002492, HPA032120, HPA032121 Supported Tissue enhanced 0 lymph node: 244.2;spleen: 212.9 appendix: 133.5 CD3D T3D ENSG00000167286 CD3d molecule, delta (CD3-TCR complex) 11 118338954-118342744 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013055 Supported Tissue enhanced 0 lymph node: 202.6;tonsil: 124.1 appendix: 90.4 CD3E ENSG00000198851 CD3e molecule, epsilon (CD3-TCR complex) 11 118304545-118316175 CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000010, HPA040957, HPA043955, CAB072863, CAB072864 Supported Tissue enhanced 0 lymph node: 203.4;tonsil: 118.2 appendix: 97.3 CD3G ENSG00000160654 CD3g molecule, gamma (CD3-TCR complex) 11 118344344-118355161 CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017520, HPA038494 Supported Tissue enhanced 0 lymph node: 31.8;tonsil: 19.7 spleen: 16.3 CD40LG CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP ENSG00000102245 CD40 ligand X 136648193-136660390 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045827 Supported Tissue enhanced 0 lymph node: 19.0;tonsil: 14.7 appendix: 10.9 CD48 BCM1, BLAST, hCD48, mCD48, SLAMF2 ENSG00000117091 CD48 molecule 1 160678746-160711851 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002497, HPA055146 Supported Supported Nucleoli fibrillar center
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 315.8;spleen: 216.7;tonsil: 235.9 appendix: 153.7 CD5 LEU1, T1 ENSG00000110448 CD5 molecule 11 61102395-61127852 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015392, CAB020308, HPA043416, HPA060839 Supported Tissue enhanced 0 appendix: 31.0;lymph node: 43.6 tonsil: 21.1 CD6 Tp120 ENSG00000013725 CD6 molecule 11 60971680-61020377 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002489, CAB016252 Supported Tissue enhanced 0 appendix: 29.5;lymph node: 49.8 tonsil: 27.7 CD69 CLEC2C ENSG00000110848 CD69 molecule 12 9752486-9760901 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002503, HPA050525 Supported Tissue enhanced 0 bone marrow: 106.2;lymph node: 110.6 appendix: 66.2 CD7 GP40, LEU-9, Tp40, TP41 ENSG00000173762 CD7 molecule 17 82314868-82317602 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002594, HPA039079 Supported Tissue enhanced 0 appendix: 44.8;lymph node: 42.1;spleen: 44.0 small intestine: 17.4 CD80 B7-1, B7.1, CD28LG, CD28LG1 ENSG00000121594 CD80 molecule 3 119524293-119559602 CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025368, HPA050092 Supported Tissue enhanced 0 appendix: 7.4;lymph node: 6.8;tonsil: 6.1 spleen: 4.6 CD84 hCD84, mCD84, SLAMF5 ENSG00000066294 CD84 molecule 1 160541095-160579516 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070502 Supported Tissue enhanced 0 lymph node: 28.8 appendix: 27.5 CD8B CD8B1 ENSG00000172116 CD8b molecule 2 86815339-86861924 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB004353, HPA029164 Approved Supported Plasma membrane Tissue enhanced 0 cervix, uterine: 60.5;lymph node: 40.2 parathyroid gland: 22.4 CD96 TACTILE ENSG00000153283 CD96 molecule 3 111292719-111665750 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066754 Supported Tissue enhanced 0 lymph node: 28.4 urinary bladder: 17.4 CENPA CenH3, CENP-A ENSG00000115163 Centromere protein A 2 26764289-26801067 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008371, HPA073086 Supported Supported Nucleus Tissue enhanced 0 lymph node: 7.5 tonsil: 6.7 CENPM C22orf18, CENP-M, MGC861, Pane1 ENSG00000100162 Centromere protein M 22 41938721-41947164 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042404, HPA056500 Supported Validated Cytosol Tissue enhanced 0 lymph node: 28.9 bone marrow: 17.6 CHMP7 MGC29816 ENSG00000147457 Charged multivesicular body protein 7 8 23243637-23262000 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036119 Uncertain Supported Nucleus
Cytosol Tissue enhanced 0 lymph node: 39.0 tonsil: 26.4 CLEC2D CLAX, LLT1, OCIL ENSG00000069493 C-type lectin domain family 2, member D 12 9664969-9699555 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017649, HPA047584 Uncertain Approved Nucleoplasm
Golgi apparatus Tissue enhanced 0 lymph node: 64.2 tonsil: 39.5 CLEC4C BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL ENSG00000198178 C-type lectin domain family 4, member C 12 7729415-7751605 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029432 Approved Tissue enhanced 0 lymph node: 6.1;spleen: 4.7;tonsil: 4.7 breast: 1.8 CLEC9A CD370, DNGR-1, HEEE9341, UNQ9341 ENSG00000197992 C-type lectin domain family 9, member A 12 10030677-10066027 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 8.0;spleen: 6.7 testis: 5.4 CLECL1 DCAL1 ENSG00000184293 C-type lectin-like 1 12 9715860-9733299 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 lymph node: 29.1;spleen: 23.2;tonsil: 29.6 appendix: 13.7 COL19A1 ENSG00000082293 Collagen, type XIX, alpha 1 6 69866571-70209976 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042422 Uncertain Tissue enhanced 0 lymph node: 3.2;tonsil: 3.0 spleen: 2.1 CRTAM CD355 ENSG00000109943 Cytotoxic and regulatory T cell molecule 11 122838500-122872639 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054595 Uncertain Tissue enhanced 0 lymph node: 10.0 spleen: 5.0 CTB-133G6.1 ENSG00000263264 19 7348943-7383385 Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA049151 Uncertain Tissue enhanced 0 lymph node: 22.6;spleen: 16.8 appendix: 16.0 CTD-2192J16.24 ENSG00000269590 19 12664828-12669397 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA065685 Approved Nuclear membrane
Endoplasmic reticulum Tissue enhanced 0 lymph node: 2.0 duodenum: 1.3 CTD-2207O23.3 ENSG00000268861 19 7382834-7472477 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA042689, HPA071867 Supported Uncertain Cytosol Tissue enhanced 0 lymph node: 17.4 spleen: 12.1 CTLA4 CD, CD152, CD28, CELIAC3, GSE, ICOS, IDDM12 ENSG00000163599 Cytotoxic T-lymphocyte-associated protein 4 2 203867786-203873960 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 appendix: 24.2;lymph node: 32.3 tonsil: 15.9 CXCL9 CMK, crg-10, Humig, MIG, SCYB9 ENSG00000138755 Chemokine (C-X-C motif) ligand 9 4 76001275-76007488 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 332.0 appendix: 89.3 CXCR3 CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR ENSG00000186810 Chemokine (C-X-C motif) receptor 3 X 71615916-71618517 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045942 Supported Tissue enhanced 0 lymph node: 18.1 spleen: 8.9 CXCR5 BLR1, CD185, MDR15 ENSG00000160683 Chemokine (C-X-C motif) receptor 5 11 118883766-118897799 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026149, HPA042432 Supported Tissue enhanced 0 lymph node: 32.9;spleen: 21.7;tonsil: 16.2 appendix: 15.1 CYTIP B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP ENSG00000115165 Cytohesin 1 interacting protein 2 157414619-157488961 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007191 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 103.1;tonsil: 106.0 appendix: 95.3 DENND1C FAM31C, FLJ22757 ENSG00000205744 DENN/MADD domain containing 1C 19 6467207-6482557 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042758, HPA042839 Supported Tissue enhanced 0 appendix: 29.2;lymph node: 37.6;spleen: 32.3 tonsil: 14.5 DENND2D FLJ22457, RP5-1180E21.2 ENSG00000162777 DENN/MADD domain containing 2D 1 111187174-111204535 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043630, HPA048642 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 112.2 tonsil: 80.0 EAF2 BM040, TRAITS, U19 ENSG00000145088 ELL associated factor 2 3 121835183-121886526 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA008411 Supported Tissue enhanced 0 lymph node: 64.5 bone marrow: 47.9 EML6 FLJ42562 ENSG00000214595 Echinoderm microtubule associated protein like 6 2 54723499-54972025 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA062808, HPA068759 Uncertain Approved Vesicles
Mitochondria Tissue enhanced 0 lymph node: 7.6;tonsil: 8.7 appendix: 4.6 EOMES TBR2 ENSG00000163508 Eomesodermin 3 27715949-27722711 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028896 Uncertain Tissue enhanced 0 lymph node: 18.4;spleen: 19.7 tonsil: 5.6 FAM159A MGC52498 ENSG00000182183 Family with sequence similarity 159, member A 1 52633344-52669683 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030744 Uncertain Tissue enhanced 0 lymph node: 8.9;tonsil: 6.9 spleen: 4.6 FAM65B C6orf32, DIFF48, KIAA0386, MYONAP ENSG00000111913 Family with sequence similarity 65, member B 6 24804282-25042168 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 92.4 spleen: 73.0 FAM72B RP11-439A17.6 ENSG00000188610 Family with sequence similarity 72, member B 1 121167646-121185539 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043271, HPA067321 Uncertain Approved Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 9.8 tonsil: 6.4 FAM72C RP5-998N21.9 ENSG00000263513 Family with sequence similarity 72, member C 1 143955364-143971965 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA043271, HPA067321 Uncertain Approved Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 5.6;tonsil: 4.4 testis: 3.0 FAM72D ENSG00000215784 Family with sequence similarity 72, member D 1 145096000-145112696 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043271, HPA067321 Uncertain Approved Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 5.7 tonsil: 4.2 FASLG APT1LG1, CD178, FasL, TNFSF6 ENSG00000117560 Fas ligand (TNF superfamily, member 6) 1 172659018-172666874 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA054959 Approved Tissue enhanced 0 lymph node: 5.9 spleen: 5.2 FCAMR CD351, FCA/MR, FKSG87 ENSG00000162897 Fc receptor, IgA, IgM, high affinity 1 206957965-206970625 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 kidney: 32.0;lymph node: 14.1;tonsil: 11.7 appendix: 5.4 FCHO1 KIAA0290 ENSG00000130475 FCH domain only 1 19 17747718-17788568 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041653, HPA062981 Approved Validated Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 29.2 spleen: 20.5 FCMR FAIM3, TOSO ENSG00000162894 Fc fragment of IgM receptor 1 206904386-206923247 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003910 Approved Approved Nucleus
Focal adhesion sites
Cytosol Tissue enhanced 0 lymph node: 178.0;spleen: 150.5;tonsil: 152.4 appendix: 91.5 FCRL1 CD307a, FCRH1, IFGP1, IRTA5 ENSG00000163534 Fc receptor-like 1 1 157794403-157820105 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013323 Approved Tissue enhanced 0 lymph node: 30.7;spleen: 23.9;tonsil: 20.7 appendix: 13.0 FCRL5 BXMAS1, CD307e, FCRH5, IRTA2 ENSG00000143297 Fc receptor-like 5 1 157513377-157552520 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 29.1;spleen: 20.8;tonsil: 33.8 appendix: 18.5 FDCSP C4orf7, FDC-SP ENSG00000181617 Follicular dendritic cell secreted protein 4 70226071-70235252 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014326, CAB014890 Supported Tissue enhanced 0 lymph node: 1027.1;salivary gland: 1383.1;tonsil: 2557.5 appendix: 372.9 FGD3 FLJ00004, ZFYVE5 ENSG00000127084 FYVE, RhoGEF and PH domain containing 3 9 92947451-93036236 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020963, HPA021018 Approved Approved Nucleus
Cytosol Tissue enhanced 0 lymph node: 31.8 spleen: 29.5 FLT3 CD135, FLK2, STK1 ENSG00000122025 Fms-related tyrosine kinase 3 13 28003274-28100592 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047539 Approved Endoplasmic reticulum Tissue enhanced 0 lymph node: 7.1;spleen: 7.8 appendix: 4.0 FUT7 ENSG00000180549 Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) 9 137030174-137033010 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042780 Approved Golgi apparatus Tissue enhanced 0 lymph node: 3.7;spleen: 2.7 tonsil: 2.1 FYB FYB-120/130, SLAP-130 ENSG00000082074 FYN binding protein 5 39105236-39274528 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025336, HPA026796 Supported Approved Plasma membrane Tissue enhanced 0 appendix: 131.1;lymph node: 111.3;spleen: 116.6 tonsil: 67.0 GCSAM GCET2, HGAL, MGC40441 ENSG00000174500 Germinal center-associated, signaling and motility 3 112120841-112133305 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002473 Approved Tissue enhanced 0 lymph node: 52.6;tonsil: 55.8 skin: 26.2 GLYATL1P3 ENSG00000255151 Glycine-N-acyltransferase-like 1 pseudogene 3 11 59086307-59094786 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA039501 Uncertain Uncertain Golgi apparatus
Cytosol Tissue enhanced 0 breast: 10.9;lymph node: 3.5 tonsil: 2.1 GP1BA CD42b, GP1B ENSG00000185245 Glycoprotein Ib (platelet), alpha polypeptide 17 4932297-4935030 CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002496, HPA013316 Supported Tissue enhanced 0 lymph node: 17.5 tonsil: 7.9 GP5 CD42d ENSG00000178732 Glycoprotein V (platelet) 3 194394821-194398354 CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 fallopian tube: 1.2;lymph node: 1.3 appendix: 0.9 GPR174 FKSG79 ENSG00000147138 G protein-coupled receptor 174 X 79170972-79172229 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA041025 Supported Uncertain Vesicles Tissue enhanced 0 lymph node: 30.2;spleen: 16.9;tonsil: 17.8 appendix: 13.1 GPR18 ENSG00000125245 G protein-coupled receptor 18 13 99254714-99261744 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013873 Supported Tissue enhanced 0 lymph node: 52.2;testis: 25.1;tonsil: 32.9 appendix: 17.0 GPR31 12-HETER, HETER1 ENSG00000120436 G protein-coupled receptor 31 6 167156271-167158329 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014014, HPA027108 Uncertain Tissue enhanced 0 lymph node: 1.6 spleen: 0.9 GPSM3 AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1 ENSG00000213654 G-protein signaling modulator 3 6 32190766-32195523 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 appendix: 25.7;lymph node: 27.9;spleen: 29.8 tonsil: 16.1 GRAP ENSG00000154016 GRB2-related adaptor protein 17 19020673-19047637 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046595, HPA066654 Uncertain Approved Centrosome Tissue enhanced 0 lymph node: 31.4;spleen: 25.7 tonsil: 20.4 GRAP2 GADS, GRBLG, GrbX, Grf40, Mona ENSG00000100351 GRB2-related adaptor protein 2 22 39901082-39973721 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005788, CAB022073 Supported Tissue enhanced 0 lymph node: 18.2 spleen: 13.1 GRAPL ENSG00000189152 GRB2-related adaptor protein-like 17 19127469-19159176 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA051796, HPA066654 Uncertain Approved Centrosome Tissue enhanced 0 lymph node: 27.1;spleen: 32.6 tonsil: 22.4 GZMB CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT ENSG00000100453 Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) 14 24630954-24634267 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000376, HPA003418 Supported Tissue enhanced 0 lymph node: 40.7 spleen: 36.7 GZMK PRSS, TRYP2 ENSG00000113088 Granzyme K (granzyme 3; tryptase II) 5 55024253-55034570 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063181 Supported Tissue enhanced 0 lymph node: 105.6 spleen: 42.5 GZMM LMET1, MET1 ENSG00000197540 Granzyme M (lymphocyte met-ase 1) 19 544034-549924 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015624 Supported Tissue enhanced 0 lymph node: 21.3;spleen: 20.1 appendix: 13.4 HAPLN3 EXLD1, HsT19883 ENSG00000140511 Hyaluronan and proteoglycan link protein 3 15 88877288-88895626 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039237 Uncertain Approved Plasma membrane
Cytosol Tissue enhanced 0 appendix: 14.3;lymph node: 11.0 spleen: 4.0 HIST1H1B H1.5, H1b, H1F5, H1s-3 ENSG00000184357 Histone cluster 1, H1b 6 27866849-27867529 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012241, HPA055907 Uncertain Supported Nucleoplasm Tissue enhanced 0 bone marrow: 6.2;lymph node: 2.6 urinary bladder: 0.9 HIST1H2BI H2B/k, H2BFK ENSG00000278588 Histone cluster 1, H2bi 6 26272976-26273356 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042205, HPA043013, HPA048671 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 bone marrow: 1.9;lymph node: 1.7 testis: 0.7 HIST1H2BM dJ160A22.3, H2B/e, H2BFE ENSG00000273703 Histone cluster 1, H2bm 6 27815044-27815424 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042205, HPA043013, HPA048671 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 bone marrow: 3.3;lymph node: 2.7 tonsil: 1.5 HIST1H3J H3/j, H3FJ ENSG00000197153 Histone cluster 1, H3j 6 27890382-27893106 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042570 Supported Tissue enhanced 0 lymph node: 1.5 testis: 0.8 HLA-DQB1 CELIAC1, HLA-DQB, IDDM1 ENSG00000179344 Major histocompatibility complex, class II, DQ beta 1 6 32659467-32668383 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA013667 Uncertain Approved Golgi apparatus Tissue enhanced 0 lymph node: 292.8 lung: 269.6 HLA-DRA HLA-DRA1 ENSG00000204287 Major histocompatibility complex, class II, DR alpha 6 32439842-32445046 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002798, CAB015402, HPA050162, HPA053176 Supported Tissue enhanced 0 lung: 729.2;lymph node: 906.6 tonsil: 492.4 HLA-F ENSG00000204642 Major histocompatibility complex, class I, F 6 29722775-29738528 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 40.6 duodenum: 28.3 HMHA1 ARHGAP45, HA-1, KIAA0223 ENSG00000180448 Histocompatibility (minor) HA-1 19 1065923-1086628 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019816 Supported Tissue enhanced 0 appendix: 58.4;lymph node: 67.5;spleen: 79.4 bone marrow: 44.1 ICOS AILIM, CD278 ENSG00000163600 Inducible T-cell co-stimulator 2 203936748-203961577 CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032575 Approved Tissue enhanced 0 lymph node: 17.1;tonsil: 15.4 bone marrow: 10.9 IFNG ENSG00000111537 Interferon, gamma 12 68154768-68159747 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB010344 Approved Tissue enhanced 0 appendix: 4.9;bone marrow: 7.6;lymph node: 8.0 lung: 2.5 IKZF1 hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1 ENSG00000185811 IKAROS family zinc finger 1 (Ikaros) 7 50304124-50405101 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009247, HPA035221, HPA035222 Supported Approved Nucleoplasm
Nucleoli
Vesicles Tissue enhanced 0 lymph node: 84.0;tonsil: 58.0 appendix: 55.9 IKZF3 Aiolos, ZNFN1A3 ENSG00000161405 IKAROS family zinc finger 3 (Aiolos) 17 39757715-39864188 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017105, HPA024377 Supported Uncertain Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 45.2;spleen: 32.2;tonsil: 40.9 appendix: 26.4 IL12RB1 CD212, IL12RB ENSG00000096996 Interleukin 12 receptor, beta 1 19 18058995-18098944 CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA074414 Approved Plasma membrane Tissue enhanced 0 lymph node: 26.3 spleen: 21.1 IL16 FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16 ENSG00000172349 Interleukin 16 15 81159575-81314058 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005247, HPA018467 Supported Approved Nuclear speckles
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 156.4;tonsil: 128.4 spleen: 120.1 IL17REL FLJ41993 ENSG00000188263 Interleukin 17 receptor E-like 22 49994513-50012659 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045546 Approved Tissue enhanced 0 appendix: 3.2;lymph node: 2.4;tonsil: 4.1 stomach: 2.1 IL21 IL-21, Za11 ENSG00000138684 Interleukin 21 4 122612628-122621069 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 18.3;testis: 6.4;tonsil: 8.5 appendix: 2.7 IL21R CD360 ENSG00000103522 Interleukin 21 receptor 16 27402162-27452042 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042296 Uncertain Uncertain Plasma membrane
Cytosol Tissue enhanced 0 appendix: 16.4;lymph node: 29.2;tonsil: 18.0 spleen: 7.7 IL2RA CD25, IDDM10, IL2R ENSG00000134460 Interleukin 2 receptor, alpha 10 6010689-6062325 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002419, HPA054622 Supported Tissue enhanced 0 adipose tissue: 23.9;appendix: 20.4;lymph node: 20.7 tonsil: 12.5 IL2RG CD132, CIDX, IMD4, SCIDX1 ENSG00000147168 Interleukin 2 receptor, gamma X 71107404-71112108 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046641, HPA049691 Supported Approved Vesicles Tissue enhanced 0 lymph node: 277.4;tonsil: 290.2 appendix: 188.7 IRF4 LSIRF, MUM1 ENSG00000137265 Interferon regulatory factor 4 6 391739-411447 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002038, HPA002698, CAB013508 Supported Supported Nucleoplasm Tissue enhanced 0 lymph node: 27.4 tonsil: 25.0 IRF8 ICSBP, ICSBP1, IRF-8 ENSG00000140968 Interferon regulatory factor 8 16 85898803-85922609 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002267, HPA002531, CAB013480 Supported Validated Nucleoplasm Tissue enhanced 0 lymph node: 302.0;spleen: 209.3;tonsil: 242.0 appendix: 122.6 ISG20 CD25, HEM45 ENSG00000172183 Interferon stimulated exonuclease gene 20kDa 15 88636153-88656483 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058356 Supported Nucleus Tissue enhanced 0 lymph node: 224.9 spleen: 138.9 ITGAL CD11A, LFA-1 ENSG00000005844 Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) 16 30472658-30523185 CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025011 Supported Tissue enhanced 0 lymph node: 80.1;spleen: 82.2 appendix: 54.3 ITK EMT, LYK, PSCTK2 ENSG00000113263 IL2-inducible T-cell kinase 5 157142933-157255191 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 appendix: 20.9;lymph node: 33.6;tonsil: 23.0 spleen: 14.0 JAK3 JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK ENSG00000105639 Janus kinase 3 19 17824780-17848071 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070314 Supported Approved Cytosol Tissue enhanced 0 appendix: 49.9;lymph node: 47.2 tonsil: 28.2 KBTBD8 KIAA1842, TA-KRP ENSG00000163376 Kelch repeat and BTB (POZ) domain containing 8 3 66998307-67011210 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041285, HPA069190 Approved Tissue enhanced 0 lymph node: 24.6;tonsil: 19.7 testis: 14.6 KIAA0101 NS5ATP9, OEATC-1, p15(PAF), PAF15 ENSG00000166803 KIAA0101 15 64364311-64387687 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047929 Supported Centrosome Tissue enhanced 0 bone marrow: 90.3;lymph node: 83.5 tonsil: 60.4 KIFC1 HSET, KNSL2 ENSG00000237649 Kinesin family member C1 6 33391536-33409924 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055997, HPA062674 Supported Approved Centrosome Tissue enhanced 0 lymph node: 3.2 bone marrow: 2.8 KLHL6 FLJ00029 ENSG00000172578 Kelch-like family member 6 3 183487531-183555689 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA024512 Uncertain Tissue enhanced 0 lymph node: 35.7;tonsil: 29.9 appendix: 16.6 KLRK1 CD314, D12S2489E, KLR, NKG2-D, NKG2D ENSG00000213809 Killer cell lectin-like receptor subfamily K, member 1 12 10372353-10391874 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB021896, HPA068877 Supported Supported Plasma membrane Tissue enhanced 0 lymph node: 35.7;spleen: 53.6 tonsil: 16.7 LAIR1 CD305 ENSG00000167613 Leukocyte-associated immunoglobulin-like receptor 1 19 54351384-54370558 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011155 Supported Supported Plasma membrane Tissue enhanced 0 lymph node: 7.2 appendix: 4.3 LAIR2 CD306 ENSG00000167618 Leukocyte-associated immunoglobulin-like receptor 2 19 54497879-54510687 CD markers, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 1.4 spleen: 0.8 LAT LAT1 ENSG00000213658 Linker for activation of T cells 16 28984826-28990783 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002223, HPA011157, CAB012978 Supported Tissue enhanced 0 lymph node: 76.5 appendix: 33.0 LAT2 HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5 ENSG00000086730 Linker for activation of T cells family, member 2 7 74199652-74229834 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003462 Supported Tissue enhanced 0 lymph node: 71.0 tonsil: 61.3 LCK ENSG00000182866 LCK proto-oncogene, Src family tyrosine kinase 1 32251239-32286165 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003494, CAB003816 Supported Approved Golgi apparatus Tissue enhanced 0 appendix: 68.8;lymph node: 127.7;tonsil: 75.1 spleen: 55.2 LEF1 TCF10, TCF1ALPHA, TCF7L3 ENSG00000138795 Lymphoid enhancer-binding factor 1 4 108047545-108168956 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002087, CAB019405 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Tissue enhanced 0 lymph node: 42.2 tonsil: 29.3 LILRB1 CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7 ENSG00000104972 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 19 54617158-54637528 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 appendix: 9.1;lymph node: 6.3;spleen: 10.1 smooth muscle: 3.7 LILRB4 CD85k, HM18, ILT3, LIR-5, LIR5 ENSG00000186818 Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 19 54643889-54670359 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052807 Approved Tissue enhanced 0 appendix: 15.1;lymph node: 13.6 urinary bladder: 8.5 LMNB1 ENSG00000113368 Lamin B1 5 126776623-126837020 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005269, HPA050524, HPA053579 Supported Validated Nuclear membrane Tissue enhanced 0 lymph node: 41.9 appendix: 37.3 LRMP JAW1 ENSG00000118308 Lymphoid-restricted membrane protein 12 25021002-25108334 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002967, HPA018505 Supported Supported Nucleus
Vesicles
Cytosol Tissue enhanced 0 lymph node: 210.1;tonsil: 193.0 appendix: 65.5 LTA LT, TNFB, TNFSF1 ENSG00000226979 Lymphotoxin alpha 6 31572054-31574324 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA007729 Uncertain Tissue enhanced 0 lymph node: 1.6;spleen: 1.0 tonsil: 0.7 LY86 dJ80N2.1, MD-1 ENSG00000112799 Lymphocyte antigen 86 6 6588108-6654983 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025000, HPA044895 Approved Tissue enhanced 0 lymph node: 83.7 spleen: 67.5 LY9 CD229, hly9, mLY9, SLAMF3 ENSG00000122224 Lymphocyte antigen 9 1 160796074-160828261 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050917 Approved Tissue enhanced 0 lymph node: 35.0;spleen: 28.9;tonsil: 29.4 appendix: 18.5 MAP4K1 HPK1 ENSG00000104814 Mitogen-activated protein kinase kinase kinase kinase 1 19 38587641-38618882 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007419, CAB007754 Supported Uncertain Nucleoplasm
Plasma membrane Tissue enhanced 0 lymph node: 37.7;spleen: 24.2;tonsil: 28.3 appendix: 19.9 MDS2 ENSG00000197880 Myelodysplastic syndrome 2 translocation associated 1 23581495-23640568 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052999 Uncertain Tissue enhanced 0 lymph node: 7.8;tonsil: 4.1 spleen: 2.9 MICB PERB11.2 ENSG00000204516 MHC class I polypeptide-related sequence B 6 31494881-31511124 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064618 Approved Golgi apparatus
Vesicles Tissue enhanced 0 lymph node: 3.3 spleen: 2.8 MMP9 CLG4B ENSG00000100985 Matrix metallopeptidase 9 20 46008908-46016561 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201 Supported Approved Cytosol Tissue enhanced 0 bone marrow: 253.0;lymph node: 119.4 appendix: 85.4 MYBL1 A-myb, AMYB ENSG00000185697 V-myb avian myeloblastosis viral oncogene homolog-like 1 8 66562175-66614247 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008791, CAB017780 Uncertain Approved Nucleus
Nucleoli
Cytosol Tissue enhanced 0 lymph node: 24.5;testis: 21.3 tonsil: 15.4 MYBL2 B-MYB, BMYB ENSG00000101057 V-myb avian myeloblastosis viral oncogene homolog-like 2 20 43667019-43716496 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017114, HPA030530, HPA055416 Uncertain Validated Nucleoplasm
Cytosol Tissue enhanced 0 bone marrow: 57.1;lymph node: 68.1;tonsil: 51.7 appendix: 33.8 MYO1G HA-2 ENSG00000136286 Myosin IG 7 44962662-44979098 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021252 Supported Tissue enhanced 0 bone marrow: 27.8;lymph node: 28.0;spleen: 25.1 appendix: 22.6 NCF1 NCF1A, NOXO2, p47phox, SH3PXD1A ENSG00000158517 Neutrophil cytosolic factor 1 7 74773962-74789315 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004524, HPA047836, HPA052095 Supported Tissue enhanced 0 lymph node: 72.1;spleen: 75.3 bone marrow: 61.0 NCR3 1C7, CD337, LY117, NKp30 ENSG00000204475 Natural cytotoxicity triggering receptor 3 6 31588895-31592985 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 1.8;spleen: 1.6;tonsil: 1.2 appendix: 1.1 NLRC3 CLR16.2, FLJ00348, NOD3 ENSG00000167984 NLR family, CARD domain containing 3 16 3539033-3577400 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA048062 Supported Microtubule organizing center
Cytosol Tissue enhanced 0 lymph node: 16.7 spleen: 11.8 NPHS1 CNF, NPHN ENSG00000161270 Nephrosis 1, congenital, Finnish type (nephrin) 19 35825964-35869287 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB035555 Supported Tissue enhanced 0 kidney: 17.7;lymph node: 5.5;pancreas: 5.5 tonsil: 2.4 NUGGC C8orf80, HMFN0672, SLIP-GC ENSG00000189233 Nuclear GTPase, germinal center associated 8 28021964-28083871 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 23.2;tonsil: 22.4 liver: 11.0 OCM OCM1 ENSG00000122543 Oncomodulin 7 5879827-5886362 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA046422 Uncertain Tissue enhanced 0 lymph node: 2.5 testis: 1.5 P2RY10 P2Y10 ENSG00000078589 Purinergic receptor P2Y, G-protein coupled, 10 X 78945332-78961954 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036757, HPA065766 Approved Tissue enhanced 0 lymph node: 33.5;spleen: 23.0;tonsil: 24.9 appendix: 20.1 P2RY8 P2Y8 ENSG00000182162 Purinergic receptor P2Y, G-protein coupled, 8 X 1462572-1537107 Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003631 Supported Tissue enhanced 0 lymph node: 43.1 tonsil: 29.0 PARP15 FLJ40597, pART7 ENSG00000173200 Poly (ADP-ribose) polymerase family, member 15 3 122577602-122639047 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA075786 Approved Mitochondria Tissue enhanced 0 lymph node: 56.0;spleen: 61.8;tonsil: 51.1 appendix: 36.8 PATL2 Pat1a ENSG00000229474 Protein associated with topoisomerase II homolog 2 (yeast) 15 44665732-44711316 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 20.3;spleen: 19.6 appendix: 10.8 PAX5 BSAP ENSG00000196092 Paired box 5 9 36833275-37034185 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026269, CAB026869, HPA056394, HPA068498 Supported Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 lymph node: 49.1;spleen: 26.7;tonsil: 35.2 appendix: 20.2 PDCD1 CD279, hSLE1, PD-1, PD1, SLEB2 ENSG00000188389 Programmed cell death 1 2 241849881-241858908 CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035981, CAB038418 Supported Tissue enhanced 0 lymph node: 12.2 appendix: 3.4 PDE6G PDEG, RP57 ENSG00000185527 Phosphodiesterase 6G, cGMP-specific, rod, gamma 17 81650459-81663112 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 26.7;spleen: 34.0 placenta: 18.8 PIK3CD p110D ENSG00000171608 Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta 1 9651732-9729114 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015420, HPA044953 Approved Approved Vesicles
Cytokinetic bridge Tissue enhanced 0 lymph node: 57.2 spleen: 52.1 PLA2G2D sPLA2S ENSG00000117215 Phospholipase A2, group IID 1 20111939-20119566 Enzymes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 120.2;tonsil: 56.0 appendix: 21.3 PLCG2 ENSG00000197943 Phospholipase C, gamma 2 (phosphatidylinositol-specific) 16 81739097-81962693 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004280, HPA020099, HPA020100 Supported Approved Vesicles Tissue enhanced 0 lymph node: 79.9 tonsil: 68.3 PMCH MCH ENSG00000183395 Pro-melanin-concentrating hormone 12 102196459-102197845 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA046055, HPA061884 Supported Tissue enhanced 0 lymph node: 1.1 appendix: 0.8 PNOC N/OFQ, NOP, PPNOC ENSG00000168081 Prepronociceptin 8 28316986-28343355 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA044507, HPA056724 Supported Tissue enhanced 0 cerebral cortex: 44.3;fallopian tube: 26.0;lymph node: 29.3 tonsil: 22.9 POU2AF1 OBF1 ENSG00000110777 POU class 2 associating factor 1 11 111352252-111455630 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB011193 Approved Tissue enhanced 0 lymph node: 103.0;tonsil: 97.6 appendix: 57.6 PPP1R18 KIAA1949, phostensin ENSG00000146112 Protein phosphatase 1, regulatory subunit 18 6 30676389-30687895 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044745, HPA051000 Supported Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 lymph node: 54.0 spleen: 35.7 PTCRA PT-ALPHA, PTA ENSG00000171611 Pre T-cell antigen receptor alpha 6 42915989-42925835 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 3.2;spleen: 4.9 tonsil: 2.1 PTPN7 HEPTP, LC-PTP ENSG00000143851 Protein tyrosine phosphatase, non-receptor type 7 1 202147013-202161588 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009530, HPA019118 Approved Tissue enhanced 0 bone marrow: 25.2;lymph node: 24.6 tonsil: 20.1 PTPRCAP CD45-AP, LPAP ENSG00000213402 Protein tyrosine phosphatase, receptor type, C-associated protein 11 67435510-67438067 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043734 Supported Tissue enhanced 0 appendix: 66.5;lymph node: 92.8;spleen: 86.7 tonsil: 30.0 PVRIG C7orf15, MGC2463 ENSG00000213413 Poliovirus receptor related immunoglobulin domain containing 7 100218241-100221490 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA047497 Uncertain Approved Nucleoli
Endoplasmic reticulum Tissue enhanced 0 lymph node: 20.8;spleen: 11.3 appendix: 8.8 PYHIN1 IFIX, MGC23885 ENSG00000163564 Pyrin and HIN domain family, member 1 1 158930796-158977054 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051224 Approved Tissue enhanced 0 lymph node: 26.7;spleen: 19.5 tonsil: 11.8 RASAL3 FLJ21438 ENSG00000105122 RAS protein activator like 3 19 15451624-15464571 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043417 Approved Tissue enhanced 0 lymph node: 38.0 spleen: 25.0 RASGRP1 CalDAG-GEFII, RASGRP ENSG00000172575 RAS guanyl releasing protein 1 (calcium and DAG-regulated) 15 38488103-38565575 Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046216 Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 28.5;lymph node: 25.3 tonsil: 15.8 RASGRP2 CALDAG-GEFI ENSG00000068831 RAS guanyl releasing protein 2 (calcium and DAG-regulated) 11 64726911-64745456 Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015667 Approved Tissue enhanced 0 lymph node: 123.6;spleen: 109.0 bone marrow: 94.5 RCSD1 CapZIP, MGC21854, MK2S4 ENSG00000198771 RCSD domain containing 1 1 167630093-167706249 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016597 Supported Uncertain Nucleoplasm
Plasma membrane Tissue enhanced 0 lymph node: 108.5 tonsil: 74.2 RHOH ARHH, RhoH, TTF ENSG00000168421 Ras homolog family member H 4 40191053-40246967 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030345 Uncertain Tissue enhanced 0 lymph node: 99.6;tonsil: 80.6 appendix: 49.4 RLTPR CARMIL2, LRRC16C ENSG00000159753 RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing 16 67644919-67657569 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041402 Approved Tissue enhanced 0 appendix: 16.8;lymph node: 25.3;spleen: 15.3 tonsil: 10.4 RP11-330H6.5 ENSG00000173366 3 52221081-52231190 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 lymph node: 3.8 tonsil: 2.2 S1PR4 EDG6 ENSG00000125910 Sphingosine-1-phosphate receptor 4 19 3172346-3180332 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA060601, HPA067232 Uncertain Mitochondria Tissue enhanced 0 lymph node: 18.3;spleen: 27.0 appendix: 14.5 SASH3 753P9, CXorf9, HACS2, SH3D6C, SLY ENSG00000122122 SAM and SH3 domain containing 3 X 129779979-129795201 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001085 Supported Tissue enhanced 0 lymph node: 138.5;spleen: 100.9;tonsil: 101.1 appendix: 83.1 SCML4 dJ47M23.1 ENSG00000146285 Sex comb on midleg-like 4 (Drosophila) 6 107704104-107824317 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063326, HPA065958 Approved Validated Nucleoplasm Tissue enhanced 0 lymph node: 16.3 spleen: 11.3 SELL CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR ENSG00000188404 Selectin L 1 169690667-169711698 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002144, HPA051972 Supported Uncertain Cytosol Tissue enhanced 0 lymph node: 258.2;spleen: 222.6;tonsil: 185.9 appendix: 157.5 SEPT1 DIFF6, PNUTL3 ENSG00000180096 Septin 1 16 30378133-30395991 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041566, HPA060339 Supported Uncertain Actin filaments Tissue enhanced 0 lymph node: 16.5;spleen: 11.5 tonsil: 6.2 SH2D1A DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD ENSG00000183918 SH2 domain containing 1A X 124227868-124373197 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 36.8;spleen: 17.7 tonsil: 13.7 SHCBP1 FLJ22009 ENSG00000171241 SHC SH2-domain binding protein 1 16 46580554-46621626 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048876 Uncertain Approved Nuclear bodies
Microtubules Tissue enhanced 0 lymph node: 17.6 bone marrow: 16.7 SIRPG bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma ENSG00000089012 Signal-regulatory protein gamma 20 1629152-1657779 CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 39.4;tonsil: 26.8 appendix: 17.6 SLAMF1 CD150, SLAM ENSG00000117090 Signaling lymphocytic activation molecule family member 1 1 160608100-160647295 CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002438 Approved Tissue enhanced 0 appendix: 15.9;lymph node: 21.3;tonsil: 14.8 spleen: 8.0 SLAMF6 CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000 ENSG00000162739 SLAM family member 6 1 160485030-160523262 CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051363, HPA051903 Uncertain Tissue enhanced 0 lymph node: 71.8;spleen: 44.1;tonsil: 46.5 appendix: 28.3 SNX20 SLIC-1, SLIC1 ENSG00000167208 Sorting nexin 20 16 50666300-50681353 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043649 Uncertain Uncertain Nucleoplasm Tissue enhanced 0 appendix: 27.3;lymph node: 31.9 spleen: 26.3 SPECC1L-ADORA2A ENSG00000258555 SPECC1L-ADORA2A readthrough (NMD candidate) 22 24270898-24442356 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 15.0;lymph node: 15.2 appendix: 12.5 SPIB SPI-B ENSG00000269404 Spi-B transcription factor (Spi-1/PU.1 related) 19 50418938-50431313 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018523 Uncertain Tissue enhanced 0 appendix: 56.0;lymph node: 104.6;tonsil: 95.1 spleen: 40.0 TBC1D10C Carabin, EPI64C, FLJ00332 ENSG00000175463 TBC1 domain family, member 10C 11 67403915-67410089 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069743 Supported Approved Nuclear bodies Tissue enhanced 0 lymph node: 46.3;spleen: 38.7 appendix: 22.9 TBX21 T-bet, TBLYM ENSG00000073861 T-box 21 17 47733244-47746119 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB009524, CAB030043 Supported Tissue enhanced 0 lymph node: 8.6;spleen: 11.2 bone marrow: 6.4 TCF19 SC1 ENSG00000137310 Transcription factor 19 6 31158542-31167159 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 11.4 skin: 6.7 TCF7 TCF-1 ENSG00000081059 Transcription factor 7 (T-cell specific, HMG-box) 5 134114711-134151865 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019403, HPA058863, HPA070505 Supported Validated Nucleoplasm Tissue enhanced 0 lymph node: 111.6 appendix: 74.8 TCL1A TCL1 ENSG00000100721 T-cell leukemia/lymphoma 1A 14 95709967-95714196 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004045, HPA016604 Supported Tissue enhanced 0 lymph node: 328.5;tonsil: 204.6 spleen: 79.4 TCL1B TML1 ENSG00000213231 T-cell leukemia/lymphoma 1B 14 95686417-95692643 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA053163 Uncertain Approved Cytosol Tissue enhanced 0 lymph node: 2.5;testis: 3.6;tonsil: 2.3 placenta: 1.2 TESPA1 KIAA0748 ENSG00000135426 Thymocyte expressed, positive selection associated 1 12 54948018-54984746 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058823 Approved Tissue enhanced 0 lymph node: 47.4 tonsil: 35.9 THEMIS bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA ENSG00000172673 Thymocyte selection associated 6 127708072-127918631 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031422, HPA031425 Supported Tissue enhanced 0 lymph node: 8.6 spleen: 4.6 TIFAB ENSG00000255833 TRAF-interacting protein with forkhead-associated domain, family member B 5 135444218-135452399 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA049372 Uncertain Tissue enhanced 0 appendix: 5.0;lymph node: 6.4;tonsil: 4.7 spleen: 3.6 TIGIT DKFZp667A205, FLJ39873, VSIG9, VSTM3 ENSG00000181847 T cell immunoreceptor with Ig and ITIM domains 3 114276913-114310288 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 lymph node: 45.0 spleen: 21.0 TLR9 CD289 ENSG00000239732 Toll-like receptor 9 3 52221080-52226163 CD markers, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 3.0 spleen: 2.0 TMC8 EVER2, EVIN2 ENSG00000167895 Transmembrane channel-like 8 17 78130770-78142968 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047387, HPA054429 Uncertain Uncertain Golgi apparatus Tissue enhanced 0 lymph node: 120.4;spleen: 107.5 appendix: 75.5 TMIGD2 CD28H, IGPR-1, MGC23244 ENSG00000167664 Transmembrane and immunoglobulin domain containing 2 19 4292232-4302431 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011081 Approved Tissue enhanced 0 lymph node: 7.5 appendix: 5.7 TNFAIP8L2 FLJ23467 ENSG00000163154 Tumor necrosis factor, alpha-induced protein 8-like 2 1 151156629-151159749 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062742 Uncertain Vesicles Tissue enhanced 0 lymph node: 35.2;spleen: 39.7 appendix: 26.6 TNFRSF13B CD267, IGAD2, TACI ENSG00000240505 Tumor necrosis factor receptor superfamily, member 13B 17 16929816-16972118 CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030453 Uncertain Tissue enhanced 0 lymph node: 20.7;skeletal muscle: 22.1;spleen: 28.0;tonsil: 22.5 appendix: 12.5 TNFRSF9 4-1BB, CD137, ILA ENSG00000049249 Tumor necrosis factor receptor superfamily, member 9 1 7915894-7943165 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA071425 Approved Nucleoli
Plasma membrane Tissue enhanced 0 lymph node: 11.2;tonsil: 7.4 appendix: 5.3 TNFSF11 CD254, ODF, OPGL, RANKL, TRANCE ENSG00000120659 Tumor necrosis factor (ligand) superfamily, member 11 13 42562736-42608013 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009193, HPA045142 Supported Tissue enhanced 0 lymph node: 17.6 appendix: 6.5 TNFSF8 CD153, CD30LG ENSG00000106952 Tumor necrosis factor (ligand) superfamily, member 8 9 114893343-114930595 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 lymph node: 34.8;tonsil: 27.8 appendix: 25.1 TRAF1 EBI6 ENSG00000056558 TNF receptor-associated factor 1 9 120902393-120929173 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001852, CAB009593 Approved Approved Nucleoplasm Tissue enhanced 0 lymph node: 38.1 appendix: 28.1 TRAF3IP3 T3JAM ENSG00000009790 TRAF3 interacting protein 3 1 209756032-209782320 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040796 Approved Approved Vesicles Tissue enhanced 0 lymph node: 116.4;spleen: 83.8;tonsil: 86.0 appendix: 70.3 TRAT1 HSPC062, TCRIM, TRIM ENSG00000163519 T cell receptor associated transmembrane adaptor 1 3 108822698-108855005 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002356, CAB026130 Supported Tissue enhanced 0 appendix: 14.6;lymph node: 26.8 spleen: 11.7 TREML1 dJ238O23.3, TLT1 ENSG00000161911 Triggering receptor expressed on myeloid cells-like 1 6 41149342-41154337 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016700, HPA017860 Supported Tissue enhanced 0 lymph node: 6.6 bone marrow: 5.0 TREML2 C6orf76, dJ238O23.1, FLJ13693, TLT2 ENSG00000112195 Triggering receptor expressed on myeloid cells-like 2 6 41190277-41201194 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 appendix: 9.5;bone marrow: 10.0;lymph node: 12.0 spleen: 8.9 TTC24 ENSG00000187862 Tetratricopeptide repeat domain 24 1 156579727-156586770 Predicted intracellular proteins Evidence at protein level Evidence at protein level No evidence HPA029797, HPA029798, HPA029799 Uncertain Tissue enhanced 0 lymph node: 6.5;spleen: 3.9;tonsil: 4.4 appendix: 2.5 TXK BTKL, PSCTK5, PTK4, RLK, TKL ENSG00000074966 TXK tyrosine kinase 4 48066393-48134256 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062482 Approved Vesicles Tissue enhanced 0 lymph node: 18.1 spleen: 14.9 UBASH3A CLIP4, STS-2, TULA ENSG00000160185 Ubiquitin associated and SH3 domain containing A 21 42403447-42447681 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lymph node: 12.7 appendix: 6.9 UBD FAT10 ENSG00000213886 Ubiquitin D 6 29555515-29559925 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043710 Supported Nucleus
Nucleoli fibrillar center Tissue enhanced 0 lymph node: 96.1;tonsil: 96.3 appendix: 44.8 UHRF1 FLJ21925, ICBP90, Np95, RNF106, TDRD22 ENSG00000276043 Ubiquitin-like with PHD and ring finger domains 1 19 4903080-4962154 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049408 Supported Nucleoplasm Tissue enhanced 0 lymph node: 19.0 bone marrow: 17.5 VAV1 VAV ENSG00000141968 Vav 1 guanine nucleotide exchange factor 19 6772714-6857366 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001864 Supported Approved Cytosol Tissue enhanced 0 lymph node: 58.4 appendix: 54.5 VPREB3 8HS20 ENSG00000128218 Pre-B lymphocyte 3 22 23752743-23754468 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA003041 Supported Tissue enhanced 0 lymph node: 119.1;tonsil: 99.5 spleen: 62.3 WAS IMD2, THC, WASP, WASPA ENSG00000015285 Wiskott-Aldrich syndrome X 48676596-48691427 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002022, CAB004290 Supported Tissue enhanced 0 appendix: 71.0;lymph node: 61.6;spleen: 70.8 bone marrow: 37.6 WDFY4 C10orf64, Em:AC060234.3, FLJ45748, KIAA1607 ENSG00000128815 WDFY family member 4 10 48684876-48982956 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040634 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 47.7;spleen: 34.4;tonsil: 33.0 appendix: 23.7 XCR1 CCXCR1, GPR5 ENSG00000173578 Chemokine (C motif) receptor 1 3 46017024-46027742 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013169 Uncertain Tissue enhanced 0 lymph node: 11.0 spleen: 9.3 ZAP70 SRK, STD, ZAP-70 ENSG00000115085 Zeta-chain (TCR) associated protein kinase 70kDa 2 97713560-97739862 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002625, HPA003134 Supported Tissue enhanced 0 appendix: 37.7;lymph node: 65.2;spleen: 38.3 tonsil: 16.9 ZC3H12D C6orf95, dJ281H8.1, MCPIP4 ENSG00000178199 Zinc finger CCCH-type containing 12D 6 149446795-149485061 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036897 Uncertain Supported Nucleoplasm
Cytoplasmic bodies Tissue enhanced 0 appendix: 9.9;lymph node: 11.7;tonsil: 12.1 spleen: 6.1 ZNF101 DKFZp570I0164, HZF12 ENSG00000181896 Zinc finger protein 101 19 19668796-19683509 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023449, HPA055486 Uncertain Tissue enhanced 0 lymph node: 31.9 tonsil: 23.3 ZNF831 C20orf174, dJ492J12.1 ENSG00000124203 Zinc finger protein 831 20 59191020-59259113 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA016839 Uncertain Tissue enhanced 0 lymph node: 7.3 tonsil: 3.7